Changes in Metabolite Ratios after Treatment with Rivastigmine in Alzheimer's Disease: A Nonrandomised Controlled Trial with Magnetic Resonance Spectroscopy

By Modrego Pedro J.  

CNS Drugs, Vol. 20, Iss. 10, 2006-01 ,pp. : 867-877

Adis International

Access to resources Recommend Favorite

Applications of magnetic resonance spectroscopy to chronic liver disease

By Taylor-Robinson Simon D  

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 54-60

Royal College Of Physicians

Access to resources Recommend Favorite

The contribution of magnetic resonance imaging to early diagnosis of the Alzheimer's disease

By Zharikov G.A.   Seleznyova N.D.   Kolykhalov I.V.   Bratzun A.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 387-387

Elsevier

Access to resources Recommend Favorite

Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1315-1324

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Magnetic Resonance Imaging in Detecting Intestinal Fibrosis in Crohn's Disease

By  

Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. : 1273-1279

Bentham Science Publishers

Access to resources Recommend Favorite